Clinical Research, Pharma & Healthcare FinancingNovaliq Gets FDA IND Clearance for NOV05 Uveitis TrialBusiness WireJanuary 29, 2026January 30, 2026 by Business WireJanuary 29, 2026January 30, 2026047 Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique water-free EyeSol® drug category, today announced that the U.S. Food...
